Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
SCIASCIA THOMAS
Chief Scientific Officer at Trevi Therapeutics. Filing since 29 May 2024.
CIK 0001229946
Company
Date
Role
Action
Shares
Amount
Of holding
TRVI
Trevi Therapeutics, Inc.
25 Mar 2025
Chief Scientific Officer
Sold at will
2,631
$17.36K
1.2%
TRVI
Trevi Therapeutics, Inc.
19 Aug 2024
Chief Scientific Officer
Sold at will
16,496
$48.88K
7.0%
TRVI
Trevi Therapeutics, Inc.
16 Aug 2024
Chief Scientific Officer
Sold at will
18,660
$51.44K
7.8%
TRVI
Trevi Therapeutics, Inc.
15 Aug 2024
Chief Scientific Officer
Sold at will
12,745
$35.51K
5.5%
TRVI
Trevi Therapeutics, Inc.
14 Aug 2024
Chief Scientific Officer
Sold at will
100
$275.00
0.0%
TRVI
Trevi Therapeutics, Inc.
29 May 2024
Chief Scientific Officer
Sold at will
53,368
$136.11K
19.9%
6 decisions on file.
